Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy.
第一作者:
Joseph H,Azar
第一单位:
Division of Medical Oncology, Department of Internal Medicine.;The Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center - James.
作者:
医学主题词
人类(Humans);抗体生成(Antibody Formation);肿瘤(Neoplasms);抗体, 单克隆(Antibodies, Monoclonal);抗体, 病毒(Antibodies, Viral)
DOI
10.1172/jci.insight.163434
PMID
36749632
发布时间
2023-09-19
基金项目
P30 CA016058/CA/NCI NIH HHS/United States
R01 AI150473/AI/NIAID NIH HHS/United States
R01 CA222817/CA/NCI NIH HHS/United States
U54 CA260582/CA/NCI NIH HHS/United States
- 浏览0
JCI insight
2023年8卷6期
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



